- Conditions
- Pruritus, Atopic Dermatitis
- Interventions
- Serlopitant High Dose, Placebo Oral Tablet, Serlopitant Low Dose
- Drug
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Eligibility
- 13 Years and older
- Enrollment
- 484 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 52
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Hoover, Alabama + 44 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 289–312
of 711
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Moderate-to-Severe Atopic Dermatitis, Atopic Eczema
- Interventions
- dupilumab, Topical emollient (moisturizer)
- Drug · Other
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Montgomery, Alabama • Fremont, California + 20 more
- Conditions
- Psoriasis, Atopic Dermatitis
- Interventions
- XmAb27564, Placebo
- Biological
- Lead sponsor
- Xencor, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 6
- States / cities
- Sherman Oaks, California • Thousand Oaks, California • Coral Gables, Florida + 3 more
- Conditions
- Dermatitis, Atopic, Eczema
- Interventions
- Desonide Cream, Amino Acid Moisturizing Cream
- Drug · Other
- Lead sponsor
- NeoStrata Company, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Asthma in Children, Atopy, Viral Upper Respiratory Infection
- Interventions
- Omalizumab, Placebo
- Drug
- Lead sponsor
- Children's National Research Institute
- Other
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Atopic Dermatitis
- Interventions
- Apremilast
- Drug
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Eczema, Atopic Dermatitis
- Interventions
- Experimental: B244
- Drug
- Lead sponsor
- AOBiome LLC
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 6
- States / cities
- Bryant, Arkansas • Los Angeles, California • Plainfield, Indiana + 3 more
- Conditions
- Atopic Dermatitis
- Interventions
- delgocitinib
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 9 more
- Conditions
- Atopic Asthma
- Interventions
- CURCUMIN, no intervention other than stopping study
- Dietary Supplement · Other
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Moderate-to-Severe Atopic Dermatitis
- Interventions
- Nemolizumab
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 2 Years to 12 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 14
- States / cities
- Fountain Valley, California • San Diego, California • Vista, California + 11 more
- Conditions
- Atopic Dermatitis
- Interventions
- Tapinarof cream, 1%
- Drug
- Lead sponsor
- Organon and Co
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 9
- States / cities
- Thousand Oaks, California • Centennial, Colorado • Coral Gables, Florida + 6 more
- Conditions
- Healthy Volunteers
- Interventions
- Abrocitinib tablet, Abrocitinib Suspension F1, Abrocitinib Suspension F2, Abrocitinib Suspension F3, Abrocitinib Suspension F4, Abrocitinib Suspension F5, Abrocitinib Suspension F6, Famotidine
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Atopic Dermatitis, Atopic Hand Eczema
- Interventions
- Tralokinumab, Placebo
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 235 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Fort Smith, Arkansas • Fountain Valley, California + 19 more
- Conditions
- Dermatitis Atopic
- Interventions
- Amlitelimab
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 999 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2031
- U.S. locations
- 22
- States / cities
- Birmingham, Alabama • Litchfield Park, Arizona • Bryant, Arkansas + 17 more
- Conditions
- Atopic Dermatitis
- Interventions
- Ruxolitinib Cream, Vehicle Cream
- Drug
- Lead sponsor
- Incyte Corporation
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 631 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 42
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 35 more
- Conditions
- Atopic Dermatitis Eczema
- Interventions
- ANB032, Placebo
- Drug
- Lead sponsor
- AnaptysBio, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 201 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 41
- States / cities
- Anaheim, California • Cerritos, California • Fountain Valley, California + 35 more
- Conditions
- Dermatitis, Atopic
- Interventions
- Educational handbook
- Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 30 Days to 16 Years
- Enrollment
- 246 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Atopic Dermatitis
- Interventions
- abrocitinib
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 12 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Lancaster, California • Long Beach, California + 16 more
- Conditions
- Atopic Dermatitis, Eczema
- Interventions
- Tralokinumab
- Drug
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- Female only
- Enrollment
- 900 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2035
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Psoriasis, Atopic Dermatitis
- Interventions
- BMX-010, Placebo
- Drug
- Lead sponsor
- BioMimetix JV, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 139 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 10
- States / cities
- Encino, California • Denver, Colorado • Englewood, Colorado + 7 more
- Conditions
- Atopic Dermatitis
- Interventions
- Atopiclair Nonsteroidal Cream, Aquaphor Healing Ointment, EpiCeram
- Drug · Other
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Atopic Dermatitis
- Interventions
- Tencel Therapeutic Garments, Cotton Therapeutic Garments
- Device
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 6 Months to 6 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Dermatitis
- Interventions
- Skin Biopsy
- Procedure
- Lead sponsor
- Hordinsky, Maria K., MD
- Individual
- Eligibility
- Up to 16 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2007
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Atopic Dermatitis
- Interventions
- Placebo for Upadacitinib, Upadacitinib
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 12 Years to 75 Years
- Enrollment
- 912 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 76
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Bryant, Arkansas + 63 more